C15orf61 Gene Associated with Erythropoietin, Immune and Blood Clotting Systems

Target Name: C15orf61

NCBI ID: G145853

C15orf61

Other Name(s): CO061_HUMAN | chromosome 15 open reading frame 61 | Uncharacterized protein C15orf61 | Chromosome 15 open reading frame 61

C15orf61 Gene Associated with Erythropoietin, Immune and Blood Clotting Systems

C15orf61 (CO061_HUMAN), also known as human single nucleotide polymorphism (SNP), is a genetic variation that has been identified in the coding region of the gene CO061. This gene is located on chromosome 15, and it codes for a protein known as human erythropoietin (Hp) subunit B. Hp is a protein that is expressed in the human body, primarily in red blood cells. It plays a crucial role in the production of erythropoietin, which is a protein that is responsible for the production of new red blood cells in the human body.

The C15orf61 gene has been identified as a SNP, which is a genetic variation that occurs at a specific position on a chromosome. SNPs occur at a rate of about one in every 2,000 individuals, and they can have a significant impact on the function and regulation of a gene.

One of the key functions of the C15orf61 gene is its role in the production of erythropoietin subunit B. Hp is a protein that is expressed in the human body, primarily in red blood cells. It plays a crucial role in the production of new red blood cells in the human body, as well as in regulating the production of erythropoietin.

In addition to its role in the production of erythropoietin subunit B, the C15orf61 gene has also been shown to be involved in the regulation of the immune system. Studies have shown that SNPs in the C15orf61 gene have been associated with changes in the immune response, including an increased risk of developing autoimmune diseases.

The C15orf61 gene has also been shown to be involved in the regulation of the blood clotting system. Studies have shown that SNPs in the C15orf61 gene have been associated with changes in the blood clotting ability of the body, including an increased risk of developing blood clots.

In conclusion, the C15orf61 gene has been identified as a SNP that is involved in the production of erythropoietin subunit B and in the regulation of the immune and blood clotting systems. These findings suggest that the C15orf61 gene may be a potential drug target or biomarker for the development of various cardiovascular and immune-related diseases. Further research is needed to fully understand the role of the C15orf61 gene in human health and disease.

Protein Name: Chromosome 15 Open Reading Frame 61

The "C15orf61 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C15orf61 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets